Semaglutide: a new GLP‐1 analogue for type 2 diabetes.
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 32, doi. 10.1002/psb.1784
- By:
- Publication type:
- Article
Works matching IS 09596682 AND DT 2019 AND VI 30 AND IP 8
Results: 7
1
2
Diagnosis and management of familial hypercholesterolaemia.
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 28, doi. 10.1002/psb.1783
- By:
- Publication type:
- Article
3
Diabetic ketoacidosis ‐ a diagnosis not to be missed.
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 25, doi. 10.1002/psb.1782
- By:
- Publication type:
- Article
4
Why isn't the NHS making the most of biosimilar insulin?
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 21, doi. 10.1002/psb.1781
- By:
- Publication type:
- Article
5
COPD update and new guidance on antibiotics for exacerbations.
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 17, doi. 10.1002/psb.1780
- By:
- Publication type:
- Article
6
The polypharmacy programme in Scotland: realistic prescribing.
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 10, doi. 10.1002/psb.1779
- By:
- Publication type:
- Article
7
Optimising investment in polypharmacy.
- Published in:
- Prescriber, 2019, v. 30, n. 8, p. 4, doi. 10.1002/psb.1778
- By:
- Publication type:
- Article